IKSNSEInventurus Knowledge Solutions Limited· IT - ServicesHighNeutral
Announced Thu, 31 Jul, 2025 · 22:08 IST

Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

IKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹1594.00
prior close
₹1649.90
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.6%+1.5% vs market
IT Enabled Services peers, median of 63sector-0.7%+0.6% vs sector

On the reaction day the stock moved 1.5 pts more than Nifty Smallcap 250 and 0.6 pts more than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.1
10m
-5.3
15m
-6.1
30m
-5.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1-1.6+1.5-0.7+0.6
Next day
-1.4-0.7-0.7-0.9-0.5
2d
-1.4-1.0-0.4-0.8-0.5
3d
-0.3-2.2+1.9-2.4+2.2
4d
+1.9-2.3+4.2-1.6+3.6
5d
+0.4-3.5+3.9-2.5+2.9
1w
-2.9-3.1+0.2-1.9-1.0
15d
+0.4-0.5+0.9-1.9+2.3
1m
-5.3-2.4-2.9-1.3-4.0
2m
-6.8-1.6-5.2-2.8-4.0
3m
+2.3+1.7+0.6-1.0+3.3
UpDownMarket · Nifty Smallcap 250Sector · IT Enabled Services peers, median of 63Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Inventurus Knowledge Solutions (IKS Health) submitted its Q1 FY26 results (quarter ended June 30, 2025). Consolidated revenue from operations grew ~15.6% year-on-year to ₹7,400.95 million, while profit after tax surged ~58.7% to ₹1,515.39 million (from ₹954.87 million). Standalone revenue jumped ~58.6% to ₹3,194.69 million and standalone PAT nearly doubled to ₹1,128.75 million. Basic EPS rose to ₹9.07 from ₹5.75 on a consolidated basis. Auditor Price Waterhouse issued an unmodified review conclusion on both standalone and consolidated results. Alongside results, the board approved several leadership changes: founder Sachin Gupta stepped down as Whole-time Director (citing personal reasons) but was designated Global CEO of the US subsidiary and continues as a Non-Executive Director; CFO Nithya Balasubramanian was elevated to Whole-time Director for five years; Garheng Albert Kong (founder of HealthQuest Capital) joined as an Independent Director; and KKC & Associates was re-appointed as internal auditor. The company also disclosed a $17 million investment acquiring 48.02% in IKS WWMG MSO LLC.

Likely market impact

PAT growth of nearly 59% comfortably exceeds the 25% threshold, signalling strong profitability expansion even though top-line growth was moderate. The leadership reshuffle looks strategic: promoting the founder to a Global CEO role at the US subsidiary, elevating the CFO, and adding a seasoned US healthcare investor as Independent Director could be viewed positively by markets focused on global growth and governance strength.